We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GTLB:NASDAQGitLab Inc. Analysis

Data as of 2026-06-22 - not real-time

$26.56

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GitLab posted a robust 23% revenue increase to $1.00 B, driven by strong AI‑related product adoption and a gross margin of 86.8%, but the company still posted a negative operating margin and a trailing EPS of –$0.15, highlighting ongoing profitability challenges. Cash on hand exceeds $1.35 B with zero debt, providing a solid balance sheet cushion, while the forward EPS estimate of $1.03 suggests a potential earnings turnaround. The current share price of $26.56 is well below the DCF‑derived fair value of $70.18, implying an upside of roughly 26% and positioning the stock as undervalued in a market characterized by an “Extreme Greed” sentiment (Fear‑Greed Index 91.46). However, the stock exhibits very high 30‑day volatility (~74%) and a beta slightly above 1, indicating heightened price swings and market‑risk sensitivity.
Technical metrics show the price trading below the 20‑day SMA (28.92) and a bearish MACD histogram, with decreasing volume and a neutral trend direction, suggesting short‑term pressure near the $25.22 support level. Nonetheless, the company’s strategic AI advancements, strong cash generation (free cash flow $313 M) and a growing top‑line provide a compelling medium‑ to long‑term growth narrative, especially given the sector’s high demand for DevSecOps solutions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD histogram
  • Support level at $25.22

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant upside vs. DCF fair value
  • 23% revenue growth and AI product momentum
  • Strong cash position with zero debt

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic positioning in high‑growth DevSecOps market
  • Improving forward EPS outlook
  • Undervalued relative to long‑term growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth23.10%
Profit Margin-2.49%
P/E Ratio25.8
ROE-2.96%
ROA-1.95%
P/B Ratio4.6
Op. Cash Flow$275.8M
Free Cash Flow$312.9M
Industry P/E38.1

Technical Analysis

TrendNeutral
RSI45.2
Support$25.22
Resistance$34.06
MA 20$28.92
MA 50$25.26
MA 200$34.45
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value$70.18
Target Price$33.61
Upside/Downside26.54%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.04
Volatility73.99%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.